Supplemental Figure 2 from PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance

Autor: Michael F. Press, Dennis J. Slamon, John Mackey, Valerie Bee, Paolo Nuciforo, John Crown, Nicholas Robert, Miguel Martin, Tadeusz Pienkowski, Wolfgang Eiermann, Ivonne Villalobos, Angela Santiago, Gary A. Pestano, Mark R. Lackner, Carol O'Brien, Wafaa Elatre, Tomasz Burzykowski, Humphrey Gardner, Howard M. Stern
Rok vydání: 2023
DOI: 10.1158/1078-0432.22458984
Popis: Supplemental Figure 2. Clinical outcome based on PTEN data availability. Kaplan Meier analysis was performed for patients with PTEN data available compared to patients without PTEN data available. Disease free survival (A, C) and overall survival (B, D) are shown for BCIRG 006 (HER2-amplified) (A, B) and BCIRG 005 (HER2-non-amplified) (C, D).
Databáze: OpenAIRE